Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Cumberland Pharmaceuticals Inc
Revenue
Cumberland Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
Revenue
$39.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$81.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45B
|
CAGR 3-Years
2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$58.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$60.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$34.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
Cumberland Pharmaceuticals Inc
Revenue Breakdown
Breakdown by Geography
Cumberland Pharmaceuticals Inc
Breakdown by Segments
Cumberland Pharmaceuticals Inc
Total Revenue:
39.6m
USD
|
Product:
37.5m
USD
|
Other:
2m
USD
|
See Also
What is Cumberland Pharmaceuticals Inc's Revenue?
Revenue
39.6m
USD
Based on the financial report for Dec 31, 2023, Cumberland Pharmaceuticals Inc's Revenue amounts to 39.6m USD.
What is Cumberland Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Cumberland Pharmaceuticals Inc have been 2% over the past three years , 6% over the past five years , and 2% over the past ten years .